BLUEBIRD STRATEGIES

Lobbying for CELLTRION USA, INC. · Biopharmaceutical Company

Filing 1st Quarter - Report

1st Quarter (Jan 1 - Mar 31) 2026 · New Jersey · House · Senate · posted Apr 6, 2026

Lobbying activity 1

Health Issues

Issues related to drug pricing, FDA drug regulations

Source: federal Lobbying Disclosure Act filing. Bills are parsed from the activity descriptions.

Report a problem